G
Guilherme Dabus
Researcher at Baptist Memorial Hospital-Memphis
Publications - 122
Citations - 3560
Guilherme Dabus is an academic researcher from Baptist Memorial Hospital-Memphis. The author has contributed to research in topics: Modified Rankin Scale & Stroke. The author has an hindex of 27, co-authored 104 publications receiving 2807 citations. Previous affiliations of Guilherme Dabus include Northwestern University & Florida International University.
Papers
More filters
Journal ArticleDOI
First Pass Effect: A New Measure for Stroke Thrombectomy Devices.
Osama O. Zaidat,Alicia C. Castonguay,Italo Linfante,Rishi Gupta,C Martin,William E. Holloway,Nils Mueller-Kronast,Joey English,Guilherme Dabus,Tim W. Malisch,Franklin A. Marden,Hormozd Bozorgchami,Andrew R. Xavier,Ansaar T Rai,Michael T. Froehler,Aamir Badruddin,Thanh N. Nguyen,M. Asif Taqi,Michael G. Abraham,Albert J. Yoo,Vallabh Janardhan,Hashem Shaltoni,Roberta Novakovic,Alex Abou-Chebl,Peng R. Chen,Gavin W. Britz,Chung Huan J Sun,Vibhav Bansal,Ritesh Kaushal,Ashish Nanda,Raul G. Nogueira +30 more
TL;DR: The achievement of complete revascularization from a single Solitaire thrombectomy device pass (FPE) is associated with significantly higher rates of good clinical outcome and the FPE is more frequently associated with the use of balloon guide catheters and less likely to be achieved with internal carotid artery terminus occlusion.
Journal ArticleDOI
Balloon guide catheter improves revascularization and clinical outcomes with the Solitaire device: analysis of the North American Solitaire Acute Stroke Registry.
Thanh N. Nguyen,T Malisch,Alicia C. Castonguay,Rishi Gupta,Chung Huan J Sun,Coleman O. Martin,William E. Holloway,Nils Mueller-Kronast,Joey English,Italo Linfante,Guilherme Dabus,Franklin A. Marden,Hormozd Bozorgchami,Andrew R. Xavier,Ansaar T Rai,Michael T. Froehler,Aamir Badruddin,M Taqi,Michael G. Abraham,Vallabh Janardhan,Hashem Shaltoni,Roberta Novakovic,Albert J Yoo,Alex Abou-Chebl,Peng R Chen,Gavin W. Britz,Ritesh Kaushal,Ashish Nanda,Mohammad A. Issa,Hesham Masoud,Raul G Nogueira,Alexander Norbash,Osama O. Zaidat +32 more
TL;DR: Use of a BGC with the Solitaire Flow Restoration device resulted in superior revascularization results, faster procedure times, decreased need for adjunctive therapy, and improved clinical outcome.
Journal ArticleDOI
Refining Angiographic Biomarkers of Revascularization Improving Outcome Prediction After Intra-arterial Therapy
Albert J Yoo,Claus Z Simonsen,Shyam Prabhakaran,Zeshan A. Chaudhry,Mohammad A. Issa,Jennifer E. Fugate,Italo Linfante,David S Liebeskind,Pooja Khatri,Tudor G Jovin,David F. Kallmes,Guilherme Dabus,Osama O. Zaidat +12 more
TL;DR: In this article, the authors compared the prognostic performance of two commonly used reperfusion scales, Thrombolysis in Myocardial Infarction (TIMI) and Modified Thrombolic Reconstruction in Cerebral Infection (mTICI), for predicting clinical outcome using receiver-operating characteristic analysis.
Journal ArticleDOI
Preliminary experience with onyx embolization for the treatment of intracranial dural arteriovenous fistulas.
Raul G. Nogueira,Guilherme Dabus,James D. Rabinov,Clifford J. Eskey,Christopher S. Ogilvy,Joshua A Hirsch,Johnny C. Pryor +6 more
TL;DR: In the experience, the endovascular treatment of intracranial DAVFs with Onyx is feasible, safe, and highly effective with a small recurrence rate in the short-term follow-up.
Journal ArticleDOI
North American Solitaire Stent Retriever Acute Stroke registry: post-marketing revascularization and clinical outcome results
Osama O. Zaidat,Alicia C. Castonguay,Rishi Gupta,Chung Huan J Sun,Coleman O. Martin,William E. Holloway,Nils Mueller-Kronast,Joey English,Italo Linfante,Guilherme Dabus,Tim W. Malisch,Franklin A. Marden,Hormozd Bozorgchami,Andrew R. Xavier,Ansaar T Rai,Michael T. Froehler,Aamir Badruddin,Thanh N. Nguyen,M. Asif Taqi,Michael G. Abraham,Vallabh Janardhan,Hashem Shaltoni,Roberta Novakovic,Albert J Yoo,Alex Abou-Chebl,Peng R Chen,Gavin W. Britz,Ritesh Kaushal,Ashish Nanda,Mohammad A. Issa,Raul G Nogueira +30 more
TL;DR: The NASA registry demonstrated that the Solitaire FR device performance in clinical practice is comparable with the SWIFT and TREVO 2 trial results.